The Fed's Actions Have Hurt Upstart. Is the Stock a Buy?
Some companies see their entire business model hinging on one decision or governing body. While this is most often associated with biotech companies that could be a hit or fade away based on a regulatory decision, it's also been the reality for Upstart (NASDAQ: UPST).
Upstart offers an alternative way to assess creditworthiness rather than a traditional FICO score and uses artificial intelligence (AI) to assess a loan applicant. However, its business model has been turned on its head thanks to the Fed's decisions to hike interest rates. The stock has plummeted more than 90% from its highs, although Upstart has rebounded in the past few months.
So has the Fed decimated Upstart's business to the point of no return? Or is there hope for Upstart's survival?
Source Fool.com
